New York-based Pfizer will begin testing its experimental COVID-19 vaccine in children as young as 12.

The drug maker says they will begin vaccinating older teens this week in Cincinnati and then they will work to enroll 12 to 15-year-old children.

Researchers leading the trial say parents are already expressing interest in having their child participate

More than half a million children in the United States have been diagnosed with COVID-19.